Atrial fibrillation (AF) is the most common form of cardiac arrhythmia, and its prevalence is growing as the population ages. Crucial to management is prevention of stroke, which is four to five times more common in patients with AF than in those without. Warfarin, for decades the mainstay of stroke prevention in patients with AF, has been joined by four direct oral anticoagulants, which each have advantages and disadvantages. This case-based CE/CME activity for nurse practitioners (NPs) and physician assistants (PAs) offers guidance on AF-related stroke prophylaxis.
Case study with interactive benchmarking
To educate NPs and PAs on selection of individualized oral anticoagulation therapy for stroke prevention in patients with AF.
After completing this activity, participants should be better able to:
- Implement current guidelines for assessment of stroke risk and initiation of therapy in patients with nonvalvular AF
- Select anticoagulation therapy based on evidence for risks and benefits, while using shared decision-making to consider individual patient factors and preferences
NPs and PAs
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing contact hours: 0.50, which includes 0.50 hours of pharmacology credit
CNE course advisor: Mary Knudtson, DNSc, NP, University of California, Santa Cruz
This program has been reviewed and is approved for a maximum of 0.50 AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of December 22, 2017. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, the AAPA, or Boehringer Ingelheim Pharmaceuticals, Inc.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are expected to disclose to the audience any significant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Naccarelli: consultant: Daiichi Sankyo, GlaxoSmithKline, Janssen; grant/research support: Janssen.
The Planning Committee for this activity included Ruth Cohen, Margaret Inman, and Melissa Culverwell of Continuing Education Alliance; Mary Knudtson, DNSc, NP, of the University of California, Santa Cruz; and Mark Christiansen, PhD, PA-C, of the University of the Pacific. The members of the Planning Committee have no significant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the eCase in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 66%.
The estimated time to complete this activity is 0.50 hours.
Release date: December 22, 2017
Expiration date: December 22, 2018
© 2018 Practicing Clinicians Exchange. All Rights Reserved. BIPCE93017